Company
United StatesPublic company, NASDAQ: TVTXTravere Therapeutics, Inc. (NASDAQ: TVTX), San Diego, CA – FDA Inspections
Inspection records and compliance data for Travere Therapeutics, Inc. in San Diego, California. 2 FDA inspections on record, last inspected September 12, 2024. Publicly traded as NASDAQ: TVTX.
Company Profile
This profile covers Travere Therapeutics, Inc. based in San Diego, California, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected June 23, 2022. Last inspected September 12, 2024.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 12, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1249942 |
| June 23, 2022 | NAI | Human Drugs · Bioresearch Monitoring | 1174875 |
FDA documents
EIRs (1)
People (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Travere Therapeutics, Inc.
Stock ticker
TVTX
Exchange
NASDAQ
Share price
$51.56
Market cap
$4.9B
Price as of
November 13, 2026
FEI Number
3018103118
Address
3611 Valley Centre Dr Ste 300, San Diego, California 92130, United States
Country
United States
ID: a6c4209e-7c15-4a5f-9ff2-8ab137141d41